A novel benzothiazole-1,2,3-triazole-based arene osmium(<sc>ii</sc>) complex as an effective rhabdomyosarcoma cancer stem cell agent

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68081707%3A_____%2F25%3A00617107" target="_blank" >RIV/68081707:_____/25:00617107 - isvavai.cz</a>
Result on the web
<a href="https://pubs.rsc.org/en/content/articlelanding/2025/qi/d4qi02737j" target="_blank" >https://pubs.rsc.org/en/content/articlelanding/2025/qi/d4qi02737j</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1039/d4qi02737j" target="_blank" >10.1039/d4qi02737j</a>

Result language
angličtina
Original language name
A novel benzothiazole-1,2,3-triazole-based arene osmium(<sc>ii</sc>) complex as an effective rhabdomyosarcoma cancer stem cell agent
Original language description
An osmium-based compound targeting cancer stem cell (CSC)-enriched rhabdosarcoma cells has been introduced. The report highlights the potential of osmium complex for a CSC-targeted therapy, addressing the need for treatments that prevent relapse and metastasis.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10402 - Inorganic and nuclear chemistry

Project
<a href="/en/project/GA23-06316S" target="_blank" >GA23-06316S: Medicinal biophysics and biochemistry of light-activated metallodrugs for targeted cancer therapy.</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)